USCACA Board of Director Member in the News

Submitted by admin on Fri, 03/20/2015 - 09:20

Jan. 21st, 2015, Paris

2014 Chinese Clinical Oncology Advances Awards Announced

Submitted by admin on Thu, 02/05/2015 - 01:38

2014 Chinese Clinical Oncology Advances Awards Announced
From China Medical Tribune

USCACA sponsor - Chipscreen has its drug approved in China

Submitted by admin on Wed, 02/04/2015 - 01:19

Chipscreen Biosciences Announces CFDA Approval of Chidamide (Epidaza) for PTCLs in China
SHENZHEN, China, Jan. 09, 2015 /PRNewswire/ -- Chipscreen Biosciences today announced regulatory approval of Chidamide (Epidaza®), the world first orally administrated and subtype-selective histone deacetylase (HDAC) inhibitor for relapsed or refractory peripheral T-cell lymphoma (PTCL) patients, in China on Dec. 23, 2014 by the Chinese Food and Drug Administration (CFDA).

International Collaboration Drives Discovery of Link Between Breast/Ovarian Cancer Gene and Stomach Cancer

Submitted by admin on Sat, 01/24/2015 - 08:23

BETHESDA, Md., Jan. 16, 2015 /PRNewswire-USNewswire/ -- A team of scientists from the United States and China has discovered new genetic insights that could change the way oncologists treat gastric cancer, the fourth most common cancer and the second leading cause of cancer death in the world. The investigators, who tested hundreds of gastric cancer tissue samples using advanced whole-genome sequencing technology, published their discovery online on January 12 in the Proceedings of National Academy of Sciences.

Program of USCACA 2014 Annual Meeting1

Submitted by admin on Tue, 06/03/2014 - 06:38

US Chinese Anti-Cancer Association Annual Meeting at ASCO 2014
6:30 - 9:00 pm
May 30, 2014
Hilton Chicago, Salon A-5, Lower Level
720 South Michigan Avenue, Chicago, 60605

Pages